ANBT
AZN icon

American National Bank & Trust’s AstraZeneca AZN Stock Holding History

American National Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,652
Closed -$304K – 628
2025
Q4 		$304K Buy
1,652
+225
+16% +$39.5K 0.03% 199
2025
Q3 		$219K Sell
1,427
-831
-37% -$126K 0.02% 228
2025
Q2 		$316K Sell
2,258
-3
-0.1% -$420 0.03% 209
2025
Q1 		$332K Buy
2,261
+513
+29% +$74.2K 0.04% 192
2024
Q4 		$229K Hold
1,748
– – 0.03% 200
2024
Q3 		$272K Sell
1,748
-748
-30% -$121K 0.03% 181
2024
Q2 		$389K Buy
2,496
+81
+3% +$12.2K 0.05% 151
2024
Q1 		$327K Buy
2,415
+781
+48% +$103K 0.04% 160
2023
Q4 		$220K Sell
1,634
-890
-35% -$116K 0.03% 169
2023
Q3 		$342K Hold
2,524
– – 0.06% 137
2023
Q2 		$361K Hold
2,524
– – 0.06% 129
2023
Q1 		$350K Buy
2,524
+917
+57% +$123K 0.06% 127
2022
Q4 		$218K Buy
1,607
+859
+115% +$108K 0.04% 142
2022
Q3 		$82K Buy
+748
New +$94.9K 0.02% 170

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

American National Bank & Trust's AZN Position: Q1 2026 in Review

American National Bank & Trust sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,652 shares — an estimated $304K sold.

American National Bank & Trust first reported a position in AZN in Q3 2022 and held it in 14 quarters. The position peaked at $389K in Q2 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • American National Bank & Trust reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • American National Bank & Trust sold 1,652 AstraZeneca shares in Q1 2026, an estimated $304K.
  • American National Bank & Trust first reported a position in AstraZeneca in Q3 2022 and held it in 14 quarters.
  • American National Bank & Trust's AstraZeneca position peaked at $389K in Q2 2024.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on American National Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.